Select a Region North America


Paul Maurer

Principal, Specialty Consulting


Consulting (Strategy Management & Regulatory)

Paul has 30 years of life science and pharmacy benefit management experience, with a rich background in market access, business development, account management, sales management, marketing and training. In his tenure at Merck, Paul was a key contributor in the launch of 22 products and accountable for the business-to-business relationships and profitability of the Merck contracts, with a cross-section of health plan customers.

Paul’s entrepreneurial mindset and deep experience with market access, contracting and account management led him to Magellan Health, where he successfully grew new business opportunities. His depth and breadth of expertise across all payer types, specialty pharmacy, contracting, pharmacy and medical benefit design and management provide our clients with unique insights into market entry strategies and tactics.

Paul earned a BA degree in Materials Management from Michigan State University where he graduated cum laude.

Articles by Paul Maurer

Trade & Channel Strategies: Partnership Pavilion Panel

Panel Summary: The challenges of commercialization are abundant. Now more than ever, the right partner and understanding the patient journey are pivotal to commercialization success and ensuring patient access to therapy. During this panel, EVERSANA, EVOKE and UpScriptHealth experts discuss the launch and later pivot in strategy of a novel therapy. Speed to therapy initiation is crucial for patients of this indication to avoid isolation due to symptoms; however, diagnosis takes an average of 5 years and 5+ providers. There is also difficulty often associated with Rx approval. EVOKE had four full-time employees that spent 15 years working towards obtaining therapy approval but did not participate in pre-commercialization activities due […]

How Specialty Pharmacies Can Elevate Your Channel and Distribution Strategy for HCP-administered Buy & Bill Products

A successful channel and distribution strategy for Buy & Bill (B&B) products should be centered around the partners you sell to and through. That means considering any third-party logistics (3PL) providers, specialty distributors (SD) and specialty pharmacies (SP) who will touch your product between the manufacturing/packaging site and patient administration. Taking a holistic view of the entire product and patient journey will give you the insight you need to make thoughtful and cost-effective decisions as you pull together this critical part of your overall strategy. Procurement and Administration Options for HCP-administered B&B Products With the continuing rise of HCP-administered therapies for multiple disease states in the last five years, it […]

Interested in scheduling a meeting or speaking event?


  • このフィールドは入力チェック用です。変更しないでください。